ARCH Venture Management, LLC Diversified Active

Location: Chicago, IL

CIK: 0001274403 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value: $230M (100.0% shares, 0.0% debt)

Holdings (9)

BEAM BEAM THERAPEUTICS INC. 48.9%

Value $113M Shares 4,540,132 Est. Cost $24.56 Unrealized +3.9%

RAPP RAPPORT THERAPEUTICS, INC. 28.7%

Value $66.15M Shares 3,728,738 Est. Cost $23.15 Unrealized -4.3%

ERAS ERASCA, INC. 12.1%

Value $27.75M Shares 11,055,554 Est. Cost $17.12 Unrealized -84.0%

— VERVE THERAPEUTICS, INC. 4.9%

Value $11.33M Shares 2,008,809 Est. Cost $36.87 Unrealized —

GOSS GOSSAMER BIO, INC. 3.2%

Value $7.287M Shares 8,055,916 Est. Cost $1.15 Unrealized -25.6%

— SINGULAR GENOMICS SYSTEMS, INC. 1.1%

Value $2.46M Shares 126,630 Est. Cost $8.45 Unrealized —

QTTB Q32 BIO INC. 0.5%

Value $1.102M Shares 320,482 Est. Cost $13.78 Unrealized +129.2%

— UNITY BIOTECHNOLOGY, INC. 0.4%

Value $981K Shares 1,004,817 Est. Cost $0.40 Unrealized —

— CERO THERAPEUTICS HOLDINGS, INC. 0.2%

Value $564K Shares 9,393,561 Est. Cost $0.52 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BEAM	BEAM THERAPEUTICS INC.	4,540,132	$113M	48.9%	$24.56	+3.9%	COM	07373V105
RAPP	RAPPORT THERAPEUTICS, INC.	3,728,738	$66.15M	28.7%	$23.15	-4.3%	COM	75383L102
ERAS	ERASCA, INC.	11,055,554	$27.75M	12.1%	$17.12	-84.0%	COM	29479A108
—	VERVE THERAPEUTICS, INC.	2,008,809	$11.33M	4.9%	$36.87	—	COM	92539P101
GOSS	GOSSAMER BIO, INC.	8,055,916	$7.287M	3.2%	$1.15	-25.6%	COM	38341P102
—	SINGULAR GENOMICS SYSTEMS, INC.	126,630	$2.46M	1.1%	$8.45	—	COM NEW	82933R308
QTTB	Q32 BIO INC.	320,482	$1.102M	0.5%	$13.78	+129.2%	COM	746964105
—	UNITY BIOTECHNOLOGY, INC.	1,004,817	$981K	0.4%	$0.40	—	COM NEW	91381U200
—	CERO THERAPEUTICS HOLDINGS, INC.	9,393,561	$564K	0.2%	$0.52	—	CLASS A COM	71902K105